Endeavor Zotarolimus Eluting Stent Post Marketing Surveillance in Japan

Endeavor Zotarolimus Eluting Stent Post Marketing Surveillance in Japan - Endeavor PMS Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010038

Enrollment

2000

Registered

2013-02-14

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: N/A

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Survival free of Major Adverse Cardiac Events (MACE) at 12 months after index procedure	—

Secondary

Measure	Time frame
Cummulative incidence rate of late and very late stent thrombosis (VLST) at 5 years after index procedure	—

Countries

Japan

Contacts

Public ContactKoichiro Oyama

Medtronic Japan Co., Ltd CV-PMS

Koichiro.oyama@medtronic.com03-6430-7686

Outcome results